Collin M. Stultz, the Nina T. and Robert H. Rubin Professor in Medical Engineering and Science at MIT, has been named co-director of the Harvard-MIT Program in Health Sciences and Technology (HST), and affiliate director of MIT’s Institute for Medical Engineering and Science (IMES), efficient June 1. IMES is HST’s residence at MIT.
Stultz is a professor {of electrical} engineering and pc science at MIT, a core school member in IMES, a member of the HST school, and a training heart specialist at Massachusetts General Hospital (MGH). He can be a member of the Research Laboratory of Electronics, and an affiliate member of the Computer Science and Artificial Intelligence Laboratory (CSAIL).
Anantha P. Chandrakasan, dean of the MIT School of Engineering and Vannevar Bush Professor of Electrical Engineering and Computer Science, praised the appointment, saying “Professor Stultz’s remarkable leadership, commitment to teaching excellence, and unwavering devotion to pursuing advancements in human health, will undoubtedly help to reinforce and bolster the missions of both IMES and HST.”
Stultz is succeeding Emery N. Brown, who was first to function HST’s co-director at MIT, following the institution of IMES in 2012. (Wolfram Goessling is the co-director of HST at Harvard University.) Brown, the Edward Hood Taplin Professor of Medical Engineering and of Computational Neuroscience at MIT, will now be specializing in the institution of a brand new joint heart between MIT and MGH that can use the research of anesthesia to design novel approaches to controlling mind states, with a objective of enhancing anesthesia and intensive care administration.
“It was a pleasure and honor for me to shepherd HST for the last 10 years,” Brown says. “I’m sure that Collin might be an exceptional co-director. He is a extremely achieved scientist, a grasp clinician, and a dedicated educator.“
George Q. Daley, dean of Harvard Medical School and an HST alumnus, says, “I am thrilled that HST’s new co-director will be a Harvard Medical School alumnus who completed clinical training and practice at our affiliated hospitals. Dr. Stultz’s remarkable expertise in computer science and AI will engender positive change as we reinvigorate this historic Harvard-MIT collaboration and redefine the scope of what it means to be a physician-scientist in the 21st century.”
Elazer R. Edelman, the Edward J. Poitras Professor in Medical Engineering and Science and the director of IMES, additionally an HST alumnus, lauded the appointment, saying, “We are so excited by the longer term, utilizing the unbelievable imaginative and prescient of Professor Stultz, his legacy of accomplishment, his dedication to mentorship, and his innate skill to meld excellence in science and medication, engineering, and physiology to propel us ahead. Everything Professor Stultz has performed predicates him and HST for achievement. “
Goessling says he appears to be like ahead to working with Stultz in his new position. “I have known Collin since our residency days at Brigham and Women’s Hospital where we cared for patients together. I am truly excited to work collaboratively and synergistically with him to now take care of our students together, to innovate our education programs and continue the legacy of success for HST.”
Stultz earned his BA magna cum laude in arithmetic and philosophy from Harvard University in 1988; a PhD in biophysics from Harvard in 1997; and an MD magna cum laude from Harvard Medical School, additionally in 1997. Stultz then went on to finish an internship and residency in inner medication, adopted by a fellowship in cardiovascular medication, on the Brigham and Women’s Hospital earlier than becoming a member of the college at MIT in 2004.
Stultz as soon as stated that his analysis focus at MIT is twofold: “the study of small things you can’t see with the naked eye, and the study of big things that you can,” and his scientific contributions have equally spanned a variety of size scales. As a graduate pupil within the laboratory of Martin Karplus — winner of the 2013 Nobel Prize in Chemistry — Stultz helped to develop computational strategies for designing ligands to versatile protein targets. As a junior school member at MIT, his group leveraged computational biophysics and experimental biochemistry to mannequin disordered proteins that play essential roles in human illness. More lately, his analysis has centered on the event and utility of machine studying strategies that allow well being care suppliers to achieve perception into patient-specific physiology, utilizing medical knowledge which might be routinely obtained in each medical and ambulatory settings.
Stultz is a member of the American Society for Biochemistry and Molecular Biology, the Federation of American Societies for Experimental Biology, and a fellow of the American Institute for Medical and Biomedical Engineering. He is a previous recipient of an Irving M. London educating award, a National Science Foundation CAREER Award, a Burroughs Wellcome Fund Career Award within the Biomedical Sciences, and he’s a latest Phi Beta Kappa visiting scholar.
“Following in the footsteps of a scholar as renowned as Emery Brown is daunting; however, I am extraordinarily optimistic about what HMS, HST, and MIT can accomplish in the years to come,” Stultz says. “I look forward to working with Elazer, Anantha, Wolfram, and the leadership at HMS to advance the educational mission of HST on the HMS campus, and throughout the MIT ecosystem.”